In fact, C5aR1 has been proposed as a therapeutic target to treat other inflammatory conditions, including inflammatory bowel disease (58), neurodegenerative diseases (59), ischemia-reperfusion injury (60), and general sepsis (61). The gene discussed is C5AR1; the disease is neurodegenerative disease.